Imatinib Tablets

Imatinib Tablets are a targeted cancer therapy used primarily to treat certain types of blood cancers such as chronic myeloid leukemia (CML) and gastrointestinal stromal tumors (GIST). By specifically inhibiting abnormal proteins that promote cancer cell growth, Imatinib helps to slow disease progression and improve patient outcomes. These tablets are prescribed under strict medical supervision and are a cornerstone of modern precision oncology, offering patients an effective option with a well-studied safety profile. Imatinib Tablets represent a significant advancement in cancer treatment, helping patients manage their condition with greater hope and improved quality of life.